Internationale Partnersuche

Innovation & Technologie Angebot

Russian company specializing in the production of adhesions gel for surgery is looking for partners in Europe.

Country of Origin: Russia
Reference Number: TORU20200531001
Publication Date: 31 May 2020

Summary

A Russian company specializing in innovation has developed surgical heliums against adhesions. The anti-adhesion gel contains hyaluronic acid, which promotes better tissue regeneration after abdominal, laparoscopic, or endoscopic operations. The company is looking for partners in Europe to conclude a manufacturing agreement.

Description

The Russian company from the Kursk region, founded in 2012, has become a manufacturer highly specialized in the production of medical materials today. 

The actual problem of modern surgery is the excessive formation of cicatricial adhesions after any injury, including after surgical interventions. The most modern direction in the prevention of adhesions (postoperative scar adhesions) is the application of barrier means (gels, membranes). Adhesions can displace organs relative to their normal localization, pull, and move them to a new, unnatural position.  Physio procedures are currently used in medicine to treat adhesions, but they do not always help soften scars (adhesions) and restore tissue elasticity. 

The Russian company has produced an innovative gel that helps fight spikes. 

Antiadhesin gel is designed to prevent adhesions after operations on organs and tissues with a serous coating (abdominal cavity, tendon sheaths, joints, pleural cavity, etc). The gel can be used in operations where there is a risk of soft tissue adhesion. For example, during operations on the neck, when there is a high risk of scar formation through all layers of the neck. The product can be used as a setting gel in plastic surgery. The therapeutic effect of the gel is associated with the creation of an artificial temporary barrier between damaged tissues, which ensures the effective separation of surfaces during their healing. After the application of the gel in the area of ​​the operative field, the substance adheres without spreading to the anatomical surfaces and forms a viscous lubricating coating. 

The gel contains highly purified sodium salt of hyaluronic acid, obtained without the use of genetically modified microorganisms. The hyaluronic acid molecule is able to retain water molecules, due to which it successfully suppresses the inflammatory process after surgery. The gel is completely safe. It consists of biologically safe biodegradable substances and is completely resorbed after 28-30 days after application. The gel is delivered with a sterile syringe with an application catheter. One package of anti-adhesive gel contains 2 syringes with a volume of 20 ml.

The company conducts and organizes training of specialists in technologies and treatment methods for various pathologies in Russia and clinics abroad. The Russian company is a regular participant in tenders and auctions and a supplier of products for medical institutions throughout Russia. The company also actively cooperates with countries such as France, Germany, Switzerland. All products have registration documents and certificates. The quality management system is certified in accordance with international standards GOST ISO 9001, GOST ISO 13485.



The Russian company is looking for foreign partners from the medical, chemical industry to conclude a manufacturing agreement. As a result of the manufacturing agreement, the Russian company will produce gel against adhesions of a certain amount under the partner’s order. In addition, a Russian company will be able to produce products to a foreign partner under a private label. The partner must specify the quantity and terms for the production order.

Advantages and Innovations

- One of the advantages of the gel is its versatility. the substance can be used for any type of surgical intervention, in which there is a risk of postoperative adhesions: operations in the abdominal and pelvic cavities, pleural cavity, pericardial cavity, on tendon sheaths, joints, and membranes of the spinal cord and brain. 

- Hydrogel has high clinical efficacy. For example, with laparoscopic surgery for the pathology of the appendages of the ovaries, the hydrogel reduces the likelihood of adhesions by 91% -93%.

- Thanks to the gel form, it can cover and envelop complex anatomical formations, penetrate into various cavities, creating a thin film-barrier on the surface of tissues.

- This gel is non-toxic and does not cause an immune reaction since it completely resolves after application.

- The company actively cooperates with various Russian clinics, where the positive dynamics of this drug were noted.

Stage Of Development

Field tested/evaluated

Stage Of Development Comment

Research laboratory tests

Requested partner

Type: SMEs, medical enterprises, chemical companies, clinics

Role: Under a manufacturing agreement, a foreign partner will order a Russian company to produce an innovative anti-adhesive gel in accordance with the requirements of standardization of products and, if necessary, to improve the composition of the gel, which will be used in various medical institutions.

Dissemination Countries

Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Germany, Denmark, Estonia, Spain, Finland, France, Greece, Croatia, Hungary, Ireland, Italy, Lithuania, Luxembourg, Latvia, Malta, Netherlands, Poland, Portugal, Romania, Sweden, Slovenia, Slovakia, United Kingdom